Swedencare AB (publ) Logo

Swedencare AB (publ)

Develops and markets premium health supplements and pharmaceuticals for cats, dogs, and horses.

SECARE | ST

Overview

Corporate Details

ISIN(s):
SE0015988167
LEI:
549300FZT7YIF6SWX789
Country:
Sweden
Address:
C/O Medeon Science Park, 205 12 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Swedencare AB is a global group that develops, produces, and markets premium pet health products, primarily for cats, dogs, and horses. The company's portfolio includes a range of strong brands offering supplements, natural and organic products, and specialty pharmaceuticals. A key component of its growth strategy is the acquisition of established companies to expand its market presence and product offerings. Swedencare utilizes a multi-channel distribution model, selling its products through a global network of veterinary clinics, pet stores, and leading e-commerce platforms like Amazon and Chewy. The company focuses on innovation and aims to outperform market growth by meeting the increasing consumer demand for high-quality pet care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Swedencare AB (publ) filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Swedencare AB (publ)

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Swedencare AB (publ) via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-24 Thomas Eklund Other Buy 12,560 426,412.00 SEK
2025-01-08 Laszlo Janos Varga Other Buy 500 22,550.00 SEK
2025-01-07 Laszlo Janos Varga Other Buy 500 23,420.00 SEK

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
Clinical-stage biopharma developing innovative targeted and immuno-oncology therapies.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
United States of America
ADVM

Talk to a Data Expert

Have a question? We'll get back to you promptly.